PartnerRe Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-9,107
Closed -$171K 61
2016
Q1
$171K Buy
9,107
+100
+1% +$1.76K 0.09% 172
2015
Q4
$166K Sell
9,007
-15,316
-63% -$274K 0.09% 183
2015
Q3
$399K Buy
24,323
+106
+0.4% +$1.81K 0.07% 210
2015
Q2
$429K Sell
24,217
-3,973
-14% -$71K 0.08% 203
2015
Q1
$500K Sell
28,190
-60
-0.2% -$948 0.08% 206
2014
Q4
$374K Buy
28,250
+3,987
+16% +$51K 0.06% 271
2014
Q3
$287K Sell
24,263
-3,861
-14% -$48.6K 0.06% 281
2014
Q2
$359K Sell
28,124
-3,878
-12% -$50.4K 0.06% 261
2014
Q1
$433K Sell
32,002
-140
-0.4% -$1.84K 0.07% 243
2013
Q4
$386K Sell
32,142
-2,084
-6% -$24.6K 0.07% 265
2013
Q3
$402K Sell
34,226
-4,701
-12% -$50.9K 0.07% 246
2013
Q2
$361K Buy
+38,927
New +$330K 0.06% 294

Other funds holding BSX

PartnerRe Asset Management's BSX Position: Q2 2016 in Review

PartnerRe Asset Management sold out of Boston Scientific (BSX) in Q2 2016, closing a stake of 9,107 shares — an estimated $171K sold.

PartnerRe Asset Management first reported a position in BSX in Q2 2013 and held it in 12 quarters. The position peaked at $500K in Q1 2015. 545 funds tracked by Wall St. Rank hold BSX as of Q2 2016.

  • PartnerRe Asset Management reported no remaining Boston Scientific position as of Q2 2016 after selling out during the quarter.
  • PartnerRe Asset Management sold 9,107 Boston Scientific shares in Q2 2016, an estimated $171K.
  • PartnerRe Asset Management first reported a position in Boston Scientific in Q2 2013 and held it in 12 quarters.
  • PartnerRe Asset Management's Boston Scientific position peaked at $500K in Q1 2015.
  • 545 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2016.

Based on PartnerRe Asset Management's 13F filing for Q2 2016, filed 14 Jul 2016.